Vaccines against coronavirus disease 2019 (COVID-19) first became available in the United
States and Europe outside clinical trials in December 2020, when administration began in …

While the research on the Omicron variant is emerging, early studies suggest a few patterns.
Several studies have estimated the effectiveness of various vaccines used around the world …

More than 215 million people in the United States are now fully vaccinated against the
SARS-CoV-2 virus responsible for COVID-19 [1]. More than 40 percent—more than 94 …

Mass-Vaccination Sites Covid-19 vaccination poses challenges that complicate the
traditional reliance on primary care delivery. Mass-vaccination sites offer a logical solution …

As COVID-19 has caused significant morbidity and mortality throughout the world, the
development and distribution of an effective vaccine have been swift but not without …

Vaccines may be scientific wonders, but their value ultimately rests on how well we can get
shots into people's arms. This is an obvious but still overlooked truth that the COVID-19 …

While waning protection from vaccination and natural infection against SARS-CoV-2
infection is well-documented, recent analyses have also found waning of protection against …

A fair shot: How to close the vaccination gap A fair shot How to close the vaccination gap
Peter Breadon and Ingrid Burfurd November 2023 A fair shot: How to close the vaccination …

Based on numbers collected through December 2022, the median COVID-19 primary series
vaccination coverage among 154 reporting countries was 59%. For people aged 60 years or …

Background Governments are trying various strategies to boost COVID-19 vaccination rates,
including vaccine mandates. Popular support for such mandates, however, is in flux in many …